ABOUT UNIVERSAL DRUG DISCOVERY
Universal Drug Discovery brings together molecular science, artificial intelligence, computational research and therapeutic discovery to accelerate the identification and evaluation of promising new medicines.
UDD is building an integrated discovery organization designed to connect large-scale molecular exploration with rigorous scientific evaluation and, as the platform grows, experimental validation.
LEADERSHIP
UDD is founder-led, with scientific, industrial and business advisors contributing complementary perspectives as the company develops its research portfolio and therapeutic programs.
Founder of Universal Drug Discovery, leading the company's scientific direction and development of computational approaches for molecular and therapeutic discovery. His work spans quantum chemistry, artificial intelligence, molecular data and computational drug discovery.
ADVISORS
A multidisciplinary advisory network supports UDD as it translates scientific research into a growing therapeutic-discovery organization.
Scientific AdvisorProfessor of Chemistry at SMU with decades of experience in theoretical and computational chemistry, including quantum-chemical method development, molecular science and drug design.
Industry AdvisorResearch advisor at Eli Lilly, bringing pharmaceutical-industry perspective to drug-discovery strategy and the translation of molecular research toward therapeutic development.
Business AdvisorExecutive Director of the William S. Spears Institute for Entrepreneurial Leadership at SMU Cox, bringing experience in strategy, entrepreneurship, company development and commercialization.
GROWING UDD
As UDD expands, the company plans to grow scientific capability across computer-assisted drug discovery, artificial intelligence, molecular modeling and therapeutic research.
Computer-Assisted Drug Discovery
Computational and molecular scientist supporting UDD’s therapeutic discovery programs, with emphasis on molecular modeling, structure-based and ligand-based analysis, candidate evaluation, and computational drug discovery.
Artificial Intelligence for Drug Discovery
AI scientist supporting UDD’s molecular discovery platform, with emphasis on machine learning, graph neural networks, molecular data, and AI-assisted identification and evaluation of promising therapeutic candidates.